EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy
about
The role of central reading centers--current practices and future directions.EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST studyAnalysis of the Serum Lipid Profile in Polypoidal Choroidal Vasculopathy.Factors influencing the outcome of polypoidal choroidal vasculopathy following combined treatment with photodynamic therapy and intravitreal ranibizumab.Efficacy and Safety of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial.Genetic influence on visual outcomes of polypoidal choroidal vasculopathy.Visual outcomes in patients with neovascular age-related macular degeneration.Visual outcomes of polypoidal choroidal vasculopathy treated with intravitreal ranibizumab with or without photodynamic therapy.Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy.Comparability of retinal thickness measurements using different scanning protocols on spectral-domain optical coherence tomography.Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom.Management of recalcitrant polypoidal choroidal vasculopathy by feeder vessel laser photocoagulation.Treatment of massive subretinal hemorrhage from polypoidal choroidal vasculopathy and age-related macular degeneration.Microperimetry and multimodal imaging in polypoidal choroidal vasculopathy
P2860
Q35848378-E66AEEEF-8A80-4D5B-B621-0F7733C8FD7AQ36008093-E1C2776A-4E94-4719-8EA2-2754697AF230Q37464734-E2E57504-7C00-42AB-A6FF-52606B5554DBQ42582890-86ECBF97-A7A2-4D9D-A02A-E3ECE715245DQ47141597-4810DDD2-3BC8-4AA7-AE5E-838B1555B690Q48133350-17B82B47-217E-4B16-9D48-88E26391836CQ48188105-94E80847-F485-461A-A46C-D29D7683233FQ48215746-5430C162-7B48-4D69-974A-6F4CD14C112AQ50215784-03FDEB39-CEEB-42FB-B93C-A20E61D509C5Q51515922-E43FAD61-140C-40BA-84E7-13382E28BBA0Q52944872-56D7A15C-0AD1-418B-8CCB-297CA561E4CFQ53678747-5E4310A9-BC1E-4202-BBFC-7C21C6D08EB5Q53697077-E4D8F629-EDCF-4092-B802-C09901D28500Q58563353-25543051-627B-4395-98DA-B23EB58CB4B5
P2860
EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
EVEREST study report 2: imagin ...... ypoidal choroidal vasculopathy
@ast
EVEREST study report 2: imagin ...... ypoidal choroidal vasculopathy
@en
type
label
EVEREST study report 2: imagin ...... ypoidal choroidal vasculopathy
@ast
EVEREST study report 2: imagin ...... ypoidal choroidal vasculopathy
@en
prefLabel
EVEREST study report 2: imagin ...... ypoidal choroidal vasculopathy
@ast
EVEREST study report 2: imagin ...... ypoidal choroidal vasculopathy
@en
P2093
P2860
P1476
EVEREST study report 2: imagin ...... ypoidal choroidal vasculopathy
@en
P2093
Colin S Tan
EVEREST Study Group
Jian Ping Chen
Nikolle W Tan
Tock Han Lim
Wei Kiong Ngo
P2860
P304
P356
10.1136/BJOPHTHALMOL-2014-305674
P407
P577
2015-03-10T00:00:00Z